Archive - February 2025
Guidance Provided for Safe Use of Ketamine
Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
Melatonin Improves DNA Damage Repair Capacity in Night Shift Workers
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Physical Activity Shows Dose-Response Relationship to Kidney Function Decline in Older Adults
U.S. FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application
States That Adopted Abortion Bans Have Higher Infant Mortality
Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo (tabelecleucel)